Centre for Human Psychopharmacology in Hawthorn, Victoria | Science website

Centre for Human Psychopharmacology

Locality: Hawthorn, Victoria

Phone: +61 3 9214 4444

Address: Swinburne University 3122 Hawthorn, VIC, Australia

Website: www.swinburne.edu.au/lss/chp

Likes: 357

Add/Update information

Reviews

Tags

• Medical and health
• Non-profit organisation
• Science website

23.01.2022 Great new paper by CHP's Sarah Catchlove along with CHP alumnus Helen Mac and Swinnie Matthew Edward Hughes !

19.01.2022 Important new CHP paper from CHP showing concordance between blood and brain biomarkers of oxidative stress. Great work Talitha Ford, Luke Downey, Tammy Simpson, Grace McPhee, Chris Oliver, Con Stough !!

18.01.2022 How important are lifestyle factors for preventing dementia? In our latest paper, we found that a combination intervention of exercise and Mediterranean diet improved working memory in older persons living independently in aged-care communities. This combination, as well as exercise alone, also improved overall well-being. Read the full text here: https://academic.oup.com/cdn/article/4/5/nzaa077/5822057 ... These exciting findings have formed the basis of our new MedWalk Study, set to start in 2021! You can read more about the trial here: http://medwalk.com.au

16.01.2022 A fun Q&A with CHP's Dr Amie Hayley! Amie recently won Swinburne's Vice Chancellor’s Award for Research Excellence (Early Career) for her work on methamphetamine and alcohol use on neurocognition and driving performance. Read more in the link below. ... https://www.swinburne.edu.au//q-and-a-with-vc-award-winne/

16.01.2022 Participants needed for a study investigating the effect of prescription benzodiazepines and alcohol on driving performance and cognition. Participants will be asked to attend Swinburne University on five separate occasions: 1 screening session for maximum 1 hours... 4 testing sessions, 1 week apart, for 3 hours each, where you will receive you will receive ONE of: alprazolam (1mg) and alcohol (0.04% BAC), alprazolam and placebo, alcohol and placebo, OR placebo only. You will be reimbursed with a $50 Coles Myer voucher for your time and travel at the completion of each testing sessions. Please contact Talitha Ford ([email protected]) for more info.

15.01.2022 Happy #clinicaltrialsday! Did you know? James Lind, a Scottish surgeon aboard the HMS Salisbury of Britain’s Royal Navy, began the first ever recorded randomized clinical trial on this day in 1747. His then termed 'fair test' investigated the effect of different treatments in 12 sailors with scurvy. James Lind even controlled for living quarters and diet! ... We now use this day to celebrate and raise awareness for the important role clinical trials play in improving public health, and recognising all those involved. #CTD2020

15.01.2022 New survey alert! We are seeking participants aged 18-50 years to share their attitudes, beliefs and behaviours related to driving under the influence of drugs You may be eligible to participate if you:... 1. Have NEVER used illicit drugs OR 2. Have EVER used/currently use methamphetamine You must also currently hold, or have held in the past, a full driver’s licence (i.e., no ‘L’ and/or ‘P’ plates, revoked full licence OK). Please click on the below link, or follow the QR code to complete the survey: https://swinuw.au1.qualtrics.com/j/form/SV_4U5gV6PvrTVUh6d

13.01.2022 Amazing work by CHPs Con Stough.

10.01.2022 CHP's Sarah Benson on Smart drugs!

10.01.2022 CHP director Andrew Scholey and PhD student Kate Cox's work on curcumin featured in goodfood.com.au. Analysis of second study nearly there! #watchthisspace

09.01.2022 CHP’s Andrew Scholey and Sarah Benson top and tailing the hangover symposium at RSA 2018 San Diego!

09.01.2022 A world-first study which has identified novel ways of detecting driver drowsiness could be the breakthrough to reducing our road toll. The trial was a collaboration between Austin Health and Swinburne’s Centre for Human Psychopharmacology. Key findings were that after being sleep deprived, drivers were three times more likely to drive out of their lane. https://www.nature.com/articles/s41598-018-20588-7

08.01.2022 Participants needed! CHP's Vision Neuroscience Lab are investigating visual processing differences between typically developing individuals with low, medium or high Autism traits. We are seeking participants that are: ... - Between 18 and 30 years old - Do not suffer from any neurological condition (epilepsy, multiple sclerosis, etc.) - Have good (corrected) vision - Have access to the internet Participation will involve completing an online questionnaire and visual pattern game. You will then be invited to download game software to a personal device and play five visual processing games from the comfort of your home! Please visit the link for more information, and contact details: https://www.swinburne.edu.au//mesurement-of-visual-proces/

07.01.2022 How has COVID-19 impacted your well-being? Let us know in the survey below! This research project aims to help us better understand the impact of the COVID-19 situation on mental health, alcohol consumption, hangover occurrence and severity, as well as identify effective and ineffective coping strategies.... The survey will be open until this Sunday 7th February. You will then be asked to complete a fallow up survey in 8 weeks time. To participate, you must be over 18, and currently living in Australia. Click the link for more information, and to take part: https://www.surveymonkey.com/r/psychologicalhealthandwellbe

06.01.2022 The current COVID-19 situation has affected how Australians live, socialise and work. We need to understand how this affects the mental health and well-being of Australians, as well as factors that may influence how people cope. The Centre for Human Psychopharmacology at Swinburne University is conducting an urgent survey on the experiences of Australians during the COVID-19 pandemic. We are looking for people living in Australia who are aged 19+ years to participate. Please... click on the link below for more information and to participate in the 45-minute survey. The survey will be open for 2 weeks from 6th May 2020 from 1.00pm (closing on 20th May 2020 at 11.59pm). It is hoped that this research will help guide support services and help them cater to the needs of Australians during this time. Please share this important survey among your family, friends and other networks. Click here to complete the adult survey: https://swinuw.au1.qualtrics.com/jfe/form/SV_74bcfF22w0mPrE1 We are also looking for adolescents aged 13-18 years to complete a similar survey to understand the impacts on this age group. If you are the parent of a child in this age group and would like to invite them to participate, please share this link with them: Click here for the adolescent survey: https://swinuw.au1.qualtrics.com/jfe/form/SV_6tyXSLteJvWJb4F Your participation in completely voluntary and your responses will remain secure and confidential. If you and/or your child choose to complete the survey, you will be emailed a reminder to complete the survey again at various time points (2 months and 4 months). As before, your participation is completely voluntary, and you may withdraw and/or remove your details at any time by emailing one of the research team below. If you have any questions, or would like further information please contact the Swinburne research team: - Prof Con Stough: [email protected], (03) 9214 8167 - Justine Lomas: [email protected], (03) 9214 5745 - Maryanne Kapoulitsas: [email protected], (03) 9214 4923 We thank you for your valuable input! This research has been approved by or on behalf of Swinburne’s Human Research Ethics Committee (SUHREC) in line with the National Statement on Ethical Conduct in Human Research. If you have any concerns or complaints about the conduct of this research, you can contact: Research Ethics Officer, Swinburne Research (H68), Swinburne University of Technology, P O Box 218, HAWTHORN VIC 3122. Tel: (03) 9214 5218 Email: [email protected]

06.01.2022 Calling 21 40 year olds: Swinburne University researchers are exploring the effects of methamphetamine on driving performance and behaviour. Would you like to participate in this study? http://www.swinburne.edu.au//methamphetamine-alcohol-driv/ ... This trial aims to assess the direct effect of combined usage of low (legal) doses of alcohol combined with methamphetamine on: Cognitive function and neurobehavioral functioning driving performance ocular activity You may be eligible to participate if you*: are aged 21 - 40 are a non-smoker have a full drivers licence have used amphetamines (any) in the past have no pre-existing medical conditions *Please note there are additional eligibility criteria to participate in this study. What does participation involve? Participation in the study will involve attending Swinburne University’s Centre for Human Psychopharmacology on five separate occasions. You will be required to attend a screening session for approximately 1.5 hours and 4 testing visits, spaced one week apart, for 3 hours each. You will be reimbursed for completing this study to cover your time and travel expenses. If you are interested in participating, please visit the study website (http://www.swinburne.edu.au//methamphetamine-alcohol-driv/) or contact one of our research team members below to discuss further: Contact Ms Klaudija Lavrans e: [email protected]

03.01.2022 How is COVID-19 affecting you? Please let us know in the surveys below!

03.01.2022 Congratulations to CHP's Greg Kennedy, winner of the 2018 Alzheimer's Award for our paper on anti-AD mechanisms of exercise (with Helen Mac). @journal_ad #fightalzheimers @alzassociation #endalz